Immunoglobulin sequence analysis and prognostication in CLL: Guidelines from the ERIC review board for reliable interpretation of problematic cases

Leukemia

Volumn 25, Issue 6, 2011, Pages 979-984

  Langerak, A W ^a   Davi, F ^b   Ghia, P ^c   Hadzidimitriou, A ^d   Murray, F ^e   Potter, K N ^f   Rosenquist, R ^e   Stamatopoulos, K ^d,g   Belessi, C ^h  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SORBONNE UNIVERSITÉ   (France)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d INFORMATION TECHNOLOGIES INSTITUTE   (Greece)

^e UPPSALA UNIVERSITY   (Sweden)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^g G PAPANICOLAOU HOSPITAL   (Greece)

^h Nikea General Hospital Athens   (Greece)

Author keywords

CLL; IGHV; immunoglobulin; prognosis; somatic mutation analysis

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY VARIABLE; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; GENE MUTATION; GENE SEQUENCE; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS;

HUMANS; IMMUNOGLOBULINS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; PROGNOSIS; REFERENCE STANDARDS; SEQUENCE ANALYSIS;

EID: 79958131059     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.49     Document Type: Article

References (25)

1. Stamatopoulos K, Ghia P, Rosenquist R (eds). New Biological Prognostic Markers in Chronic Lymphocytic Leukemia. WKHealth Books: Milan, 2010.
2. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen S et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840-1847. (Pubitemid 29430399)
3. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848-1854. (Pubitemid 29430400)
4. Ghia P, Stamatopoulos K, Belessi C, Moreno C, Stilgenbauer S, Stevenson F et al. European Research Initiative on CLL. ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia. Leukemia 2007; 21: 1-3. (Pubitemid 44921826)
5. Lefranc M-P, Giudicelli V, Ginestoux C, Jabado-Michaloud J, Folch G, Bellahcene F et al. IMGTs, the international ImMunoGeneTics information systems. Nucl Acids Res 2009; 37: D1006-D1012.
6. Brochet X, Lefranc M-P, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucl Acids Res 2008; 36: W503-W508.
7. Belessi C. Interpretation of 'trouble' sequences. In: Immunoglobulin Gene Analysis in Chronic Lymphocytic Leukemia, Chapter 3. Ghia P, Davi F, Rosenquist R (eds). WKHealth: Milan, 2008.
8. Belessi C, Davi F, Stamatopoulos K, Degano M, Andreou T, Moreno C et al. IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors. Eur J Immunol 2006; 36: 1963-1974. (Pubitemid 44089061)
9. Steenbergen EJ, Verhagen OJ, van den Berg H, van Leeuwen EF, Behrendt H, Slater RR et al. Rearrangement status of the malignant cell determines type of secondary IgH rearrangement (V-replacement or V to DJ joining) in childhood B precursor acute lymphoblastic leukemia. Leukemia 1997; 11: 1258-1265. (Pubitemid 27387302)
10. Schlissel M. Allelic exclusion of immunoglobulin gene rearrangement and expression: why and how? Semin Immunol 2002; 14: 207-212. (Pubitemid 34969906)
11. Li Y, Li H, Weigert M. Autoreactive B cells in the marginal zone that express dual receptors. J Exp Med 2002; 195: 181-188. (Pubitemid 34461262)
12. Rassenti LZ, Kipps TJ. Lack of allelic exclusion in B cell chronic lymphocytic leukemia. J Exp Med 1997; 185: 1435-1445. (Pubitemid 27187600)
13. Hadzidimitriou A, Darzentas N, Murray F, Smilevska T, Arvaniti E, Tresoldi C et al. Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia. Blood 2009; 113: 403-411.
14. Sanchez ML, Almeida J, Gonzalez D, Gonzalez M, Garcia-Marcos MA, Balanzategui A et al. Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone. Blood 2003; 102: 2994-3002. (Pubitemid 37248875)
15. Herve M, Xu K, Ng YS, Wardemann H, Albesiano E, Messmer BT et al. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J Clin Invest 2005; 115: 1636-1643. (Pubitemid 40814672)
16. Murray F, Darzentas N, Hadzidimitriou A, Tobin G, Boudjogra M, Scielzo C et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 2008; 111: 1524-1533. (Pubitemid 351213442)
17. Seiler T, Woelfle M, Yancopoulos S, Catera R, Li W, Hatzi K et al. Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells. Blood 2009; 114: 3615-3624.
18. Tobin G, Thunberg U, Johnson A, Thörn I, Söderberg O, Hultdin M et al. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002; 99: 2262-2264. (Pubitemid 34525519)
19. Ghia P, Stamatopoulos K, Belessi C, Moreno C, Stella S, Guida G et al. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood 2005; 105: 1678-1685. (Pubitemid 40223690)
20. Thorselius M, Krober A, Murray F, Thunberg U, Tobin G, Bühler A et al. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-utilizing chronic lymphocytic leukemia independent of geographical origin and mutational status. Blood 2006; 107: 2889-2894.
21. Stamatopoulos K, Belessi C, Moreno C, Boudjograh M, Guida G, Smilevska T et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 2007; 109: 259-270. (Pubitemid 46070124)
22. Bomben R, Dal Bo M, Capello D, Forconi F, Maffei R, Laurenti L et al. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. Br J Haematol 2009; 144: 492-506.
23. Oscier D, Wade R, Davis Z, Morilla A, Best G, Richards S et al. Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation. Haematologica 2010; 95: 1705-1712.
24. Lefranc M-P, Lefranc G. The Immunoglobulin FactsBook, 1st edn, Academic Press: London, 2001, pp 1-458.
25. Lefranc M-P, Pommié C, Ruiz M, Giudicelli V, Foulquier E, Truong L et al. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev Comp Immunol 2003; 27: 55-77. (Pubitemid 35449624)